The 35th CINP World Congress of Neuropsychopharmacology

Session information

[CINP2024] Short Communications

CINP2024 » Short Communications

Short Communications 6
Anxiety Disorders and Autism - Preclinical

Fri. May 24, 2024 1:30 PM - 2:45 PM Room 7 (G407)

Chair: Andrew Holmes (NIH)

*Rafael Freire1,2,3, Amir Garakani4,5, Frank Buono5, Mona Salehi6, Melissa Funaro7, Anna Klimowicz8, Harshit Sharma5, Clara Faria3, Kaitlyn Larkin9 (1. Department of Psychiatry and Centre for Neuroscience Studies, Queen's University, Kingston, Ontario, Canada, 2. Kingston General Hospital Research Institute, Kingston Health Sciences Centre, Kingston, Canada, 3. Laboratory of Panic and Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil, 4. Department of Psychiatry and Behavioral Health, Greenwich Hospital, Greenwich, CT, United States of America, 5. Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, United States of America, 6. Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America , 7. Harvey Cushing/John Hay Whitney Medical Library, Yale University, New Haven, CT, United States of America, 8. New York University Langone Psychiatry Associates, New York, NY, United States of America, 9. Department of Psychology, Northern Illinois University, DeKalb, IL, United States of America)

*Teng Gao1,2, Tang Sheng Lu2,3,5, Ying Han2,3,5, Lin Lu1,2,3,4 (1. Peking University Sixth Hospital, Peking University Institute of Mental Health, National Clinical Research Center for Mental Disorders, 2. Peking University , 3. National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, 4. Peking-Tsinghua Centre for Life Sciences and PKU-IDG/McGovern Institute for Brain Research, 5. Department of Neurobiology, Peking University Health Science Center)

*Maria Clemencia Hernandez1, Giuseppe Cecere1, Theresa M Ballard1, Michael Honer1, Joerg F Hipp1, Frederick Knoflach1, Andres Olivares1, Thomas Mueggler1, Andreas Bruns1, Pilar Graces1, Basil Kuennecke1, Barbara Biemans1, Henner Knust1, Eoin O'Connor1, Michael Saxe1, Lorraine Murtagh1 (1. Roche Pharmaceutical Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Grenzacherstrasse 124, 4070 Basel, Switzerland.)

×

Authentication

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

×

Please log in with your participant account.
» Participant Log In